PROFILE |
 |
Does Galen draw from antiquity to create medicines for today? Galen Holdings, which bears the name of ancient Greece's famous physician and writer, is the holding company for a host of pharmaceutical companies. Its subsidiary, Galen Pharma, makes some 130 prescription drugs, including analgesics, antibiotics, gastrointestinal aids, cardiovascular products, and respiratory and allergy products. Other subsidiaries provide such clinical trials services as pharmaceutical development, manufacturing, and chemical development. Still others make clinical trial supplies and clinical trials data management systems. Galen has acquired Warner Chilcott, adding that company's women's health prescription drug business to its fold.
COMPETITION |
 |
GlaxoSmithKline plc (GSK)
Merck & Co., Inc. (MRK)
Quintiles Transnational Corp. (QTRN)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: September
2000 Sales (mil.): 96.40
1-Yr. Sales Growth: 6.4%
Employees: 1,521
Revenue per employee: $63,379.36
KEY PEOPLE |
 |
Roger Biossonneault
CEO
R. Geoffrey Elliott
CFO
CONTACT INFO |
 |
Seagoe Industrial Estate
Craigavon County Armagh BT63 5UA, United Kingdom
Phone: 44-28-3833-4974
Fax: 44-28-3835-0206
Online: Web Site
|